COM:SANTEN
Santen Pharmaceutical Co., Ltd
- Stock
Last Close
1,664.00
22/11 06:45
Market Cap
650.87B
Beta: -
Volume Today
1.48M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 20.49B - | 20.08B 1.99% | 22.56B 12.36% | 26.75B 18.54% | 29.57B 10.54% | 32.94B 11.39% | 35.26B 7.05% | 38.43B 8.99% | 39.36B 2.42% | 38.25B 2.82% | |
average payables | 11.77B - | 17.26B 46.67% | 22.38B 29.65% | 24.22B 8.24% | 26.84B 10.82% | 30.91B 15.17% | 32.33B 4.59% | 35.34B 9.32% | 39.65B 12.18% | 43.06B 8.63% | |
average receivables | 50.08B - | 58.07B 15.96% | 63.85B 9.96% | 68.48B 7.26% | 74.81B 9.24% | 81.64B 9.12% | 85.81B 5.11% | 91.50B 6.63% | 97.79B 6.88% | 103.41B 5.74% | |
book value per share | 439.10 - | 512.71 16.77% | 628.37 22.56% | 616.72 1.85% | 703.28 14.04% | 716.21 1.84% | 758.76 5.94% | 770.01 1.48% | 844.19 9.63% | 758.81 10.11% | |
capex per share | -160.85 - | -21.97 86.34% | -23.15 5.36% | -24.45 5.61% | -20.52 16.09% | -23.12 12.69% | -59.59 157.76% | -89.65 50.45% | -63.47 29.21% | ||
capex to depreciation | -9.55 - | -0.97 89.80% | -0.96 1.26% | -0.91 5.13% | -0.76 16.70% | -0.56 26.71% | -1.42 154.95% | -2.10 48.03% | -1.43 32.17% | ||
capex to operating cash flow | -2.62 - | -0.40 84.58% | -0.88 117.06% | -0.23 73.53% | -0.25 9.22% | -0.23 8.81% | -0.61 165.52% | -0.78 26.91% | -0.66 14.97% | ||
capex to revenue | -0.41 - | -0.05 88.66% | -0.05 2.49% | -0.04 7.42% | -0.04 19.40% | -0.04 7.29% | -0.10 149.63% | -0.13 41.15% | -0.09 34.54% | ||
cash per share | 185.66 - | 160.05 13.79% | 241.75 51.04% | 130.70 45.94% | 171.63 31.32% | 174.96 1.94% | 230.19 31.57% | 158.75 31.03% | 210.89 32.84% | 151.46 28.18% | |
days of inventory on hand | 125.83 - | 130.36 3.60% | 125.27 3.90% | 138.77 10.78% | 129.46 6.71% | 141.69 9.45% | 135.80 4.16% | 154.50 13.77% | 123.61 19.99% | 127.17 2.88% | |
days payables outstanding | 89.64 - | 131.11 46.26% | 122.81 6.33% | 116.55 5.10% | 125.68 7.84% | 129.00 2.64% | 125.39 2.80% | 141.61 12.93% | 137.07 3.20% | 145.24 5.96% | |
days sales outstanding | 133.64 - | 139.16 4.13% | 123.35 11.36% | 130.11 5.48% | 127.63 1.91% | 131.97 3.41% | 131.46 0.39% | 140.37 6.78% | 136.52 2.74% | 140.26 2.73% | |
debt to assets | 0.00 - | ||||||||||
debt to equity | 0.00 - | ||||||||||
dividend yield | 0.02 - | 0.01 47.60% | 0.01 23.90% | 0.02 14.74% | 0.02 6.79% | 0.02 2.72% | 0.01 10.06% | 0.02 31.41% | 0.02 32.96% | 0.03 17.77% | |
earnings yield | 0.05 - | 0.03 26.54% | 0.08 129.16% | 0.03 54.25% | 0.05 45.15% | 0.05 7.13% | 0.03 32.21% | 0.01 64.75% | 0.06 394.25% | -0.03 161.68% | |
enterprise value | 314.57B - | 656.92B 108.83% | 600.74B 8.55% | 608.18B 1.24% | 627.72B 3.21% | 609.13B 2.96% | 650.20B 6.74% | 545.48B 16.11% | 407.51B 25.29% | 379.88B 6.78% | |
enterprise value over ebitda | 9.82 - | 15.24 55.14% | 6.65 56.35% | 14.06 111.28% | 12.41 11.72% | 10.69 13.82% | 12.73 19.10% | 17.78 39.64% | 7.56 57.47% | 29.34 287.88% | |
ev to operating cash flow | 12.12 - | 25.88 113.54% | 26.67 3.06% | 56.09 110.31% | 14.65 73.88% | 18.52 26.39% | 16.28 12.10% | 14.06 13.64% | 8.85 37.03% | 10.23 15.54% | |
ev to sales | 2.12 - | 4.06 91.84% | 3.08 24.22% | 3.05 0.70% | 2.79 8.65% | 2.60 6.73% | 2.69 3.42% | 2.19 18.81% | 1.53 29.97% | 1.36 11.05% | |
free cash flow per share | 62.90 - | -99.39 258.01% | 32.46 132.66% | 3.27 89.92% | 80.97 2,373.87% | 60.47 25.31% | 76.96 27.27% | 37.56 51.19% | 25.52 32.06% | 32.42 27.03% | |
free cash flow yield | 0.07 - | -0.06 182.71% | 0.02 133.76% | 0.00 89.41% | 0.05 2,225.29% | 0.04 23.49% | 0.04 14.67% | 0.02 40.46% | 0.02 15.67% | 0.03 37.93% | |
graham net net | 187.95 - | 72.71 61.32% | 161.05 121.51% | 127.25 20.99% | 106.19 16.55% | 131.79 24.11% | 171.77 30.34% | 152.44 11.25% | 136.17 10.67% | 79.73 41.45% | |
graham number | 639.99 - | 819.25 28.01% | 1.35K 64.84% | 882.94 34.62% | 1.17K 32.70% | 1.13K 3.92% | 1.01K 10.72% | 544.27 45.85% | 1.14K 108.94% | 812.58 28.54% | |
income quality | 0.97 - | 1.06 9.44% | 0.42 60.05% | 0.47 11.44% | 1.22 158.33% | 1.03 15.25% | 1.84 78.65% | 5.84 217.45% | 1.69 71.00% | -2.48 246.40% | |
intangibles to total assets | 0.07 - | 0.28 286.76% | 0.24 15.17% | 0.32 35.27% | 0.35 8.70% | 0.34 3.20% | 0.29 12.52% | 0.28 4.32% | 0.28 0.91% | 0.23 19.23% | |
interest coverage | 5.48K - | 126.79 97.69% | 53.74 57.61% | 20.75 61.38% | 89.15 329.57% | 15.65 82.44% | 14.01 10.48% | 8.68 38.06% | 29.68 241.93% | -2.87 109.66% | |
interest debt per share | 0.16 - | 0.68 335.55% | 3.61 433.82% | 3.81 5.77% | 1.07 72.00% | 7.09 564.23% | 6.00 15.48% | 3.73 37.87% | 3.02 18.81% | 3.87 27.94% | |
inventory turnover | 2.90 - | 2.80 3.48% | 2.91 4.06% | 2.63 9.73% | 2.82 7.20% | 2.58 8.64% | 2.69 4.34% | 2.36 12.10% | 2.95 24.99% | 2.87 2.80% | |
invested capital | 0.00 - | ||||||||||
market cap | 378.02B - | 722.85B 91.22% | 700.54B 3.09% | 661.47B 5.58% | 697.00B 5.37% | 679.92B 2.45% | 741.63B 9.08% | 608.37B 17.97% | 490.52B 19.37% | 437.78B 10.75% | |
net current asset value | 106.11B - | 58.25B 45.10% | 99.35B 70.55% | 88.12B 11.31% | 82.46B 6.42% | 96.13B 16.57% | 112.35B 16.87% | 110.93B 1.26% | 106.29B 4.18% | 85.44B 19.62% | |
net debt to ebitda | -1.98 - | -1.53 22.82% | -1.11 27.74% | -1.23 11.45% | -1.37 11.18% | -1.24 9.25% | -1.79 44.09% | -2.05 14.49% | -1.54 24.85% | -4.47 190.23% | |
net income per share | 41.46 - | 58.18 40.34% | 128.99 121.70% | 56.18 56.44% | 86.76 54.43% | 78.64 9.35% | 59.17 24.76% | 17.10 71.10% | 68.08 298.19% | -38.67 156.80% | |
operating cash flow per share | 62.90 - | 61.46 2.29% | 54.44 11.43% | 26.42 51.46% | 105.42 298.94% | 80.99 23.18% | 100.08 23.57% | 97.15 2.92% | 115.17 18.55% | 95.88 16.75% | |
payables turnover | 4.07 - | 2.78 31.63% | 2.97 6.76% | 3.13 5.37% | 2.90 7.27% | 2.83 2.57% | 2.91 2.88% | 2.58 11.45% | 2.66 3.31% | 2.51 5.63% | |
receivables turnover | 2.73 - | 2.62 3.97% | 2.96 12.82% | 2.81 5.19% | 2.86 1.94% | 2.77 3.29% | 2.78 0.39% | 2.60 6.35% | 2.67 2.82% | 2.60 2.66% | |
research and ddevelopement to revenue | 0.11 - | 0.10 5.22% | 0.11 11.81% | 0.11 5.23% | 0.10 6.40% | 0.10 4.82% | 0.10 0.03% | 0.10 2.55% | 0.10 2.37% | ||
return on tangible assets | 0.08 - | 0.11 37.11% | 0.20 79.63% | 0.10 46.64% | 0.14 32.48% | 0.12 11.54% | 0.08 33.44% | 0.02 71.14% | 0.08 249.83% | -0.05 155.88% | |
revenue per share | 360.23 - | 391.79 8.76% | 471.96 20.46% | 485.19 2.80% | 553.48 14.07% | 576.18 4.10% | 605.16 5.03% | 624.86 3.26% | 666.02 6.59% | 720.24 8.14% | |
roe | 0.09 - | 0.11 20.19% | 0.21 80.89% | 0.09 55.62% | 0.12 35.42% | 0.11 10.99% | 0.08 28.98% | 0.02 71.53% | 0.08 263.20% | -0.05 163.20% | |
roic | 0.10 - | 0.11 16.36% | 0.21 85.03% | 0.09 55.11% | 0.12 30.75% | 0.11 5.53% | 0.07 34.77% | 0.02 70.01% | 0.08 261.22% | -0.04 146.56% | |
sales general and administrative to revenue | 0.30 - | 0.30 0.68% | 0.31 2.69% | 0.31 2.10% | 0.30 0.41% | 0.30 0.28% | 0.32 4.95% | 0.32 0.43% | 0.34 8.70% | ||
shareholders equity per share | 439.10 - | 512.71 16.77% | 628.37 22.56% | 616.72 1.85% | 703.28 14.04% | 716.21 1.84% | 758.76 5.94% | 770.01 1.48% | 844.19 9.63% | 758.81 10.11% | |
stock based compensation to revenue | |||||||||||
tangible asset value | 164.62B - | 127.35B 22.64% | 176.33B 38.46% | 151.08B 14.32% | 153.06B 1.31% | 161.46B 5.49% | 182.71B 13.16% | 194.17B 6.27% | 206.63B 6.41% | 196.99B 4.66% | |
tangible book value per share | 398.91 - | 308.30 22.71% | 426.13 38.22% | 368.17 13.60% | 376.62 2.29% | 397.53 5.55% | 457.74 15.15% | 486.10 6.19% | 516.86 6.33% | 508.46 1.62% | |
working capital | 116.91B - | 94.33B 19.31% | 121.51B 28.81% | 103.58B 14.76% | 121.17B 16.98% | 134.08B 10.66% | 150.96B 12.59% | 127.68B 15.42% | 133.60B 4.64% | 123.82B 7.32% |
All numbers in (except ratios and percentages)